Gilmore Neil O'Neill
CIK 1742084 · CEO · last filed 2026-09-04
Gilmore Neil O'Neill is a CEO who has filed 40 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing shows the insider sold $15.6K of EDIT on Sep 4, 2026. Across all open-market trades the lifetime net is −$1.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.02M
4
40
-$1.02M
Filer Profile
CAMBRIDGE, MA 02142
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EDIT | CEO | 243,189 | $3.03 | $736.9K | -$1.02M | 16 | 2026-09-04 |
| Unity Biotechnology, Inc. (UBX) Delisted | Director | — | $0.20 | — | $0 | 5 | 2024-06-21 |
| Aptinyx Inc. (APTX) Delisted | Director | — | $0.06 | — | $0 | 2 | 2022-05-31 |
| SRPT | EVP, R&D & CMO | 13,546 | $20.94 | $283.7K | $0 | 6 | 2021-03-10 |
Recent Filings
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-04 | EDIT | Sell (S) | −5,124 | -$15.6K | EDGAR |
| 2026-08-31 | EDIT | Notice (144) | −5,100 | -$16.7K | EDGAR |
| 2026-06-05 | EDIT | Sell (S) | −15,380 | -$41.5K | EDGAR |
| 2026-05-29 | EDIT | Notice (144) | −15,000 | -$46.2K | EDGAR |
| 2026-03-16 | EDIT | Grant (A) | — | $0 | EDGAR |
| 2026-03-04 | EDIT | Sell (S) | −5,394 | -$10.9K | EDGAR |
| 2026-02-27 | EDIT | Notice (144) | −6,000 | -$11.3K | EDGAR |
| 2025-12-04 | EDIT | Sell (S) | −5,603 | -$12.1K | EDGAR |
| 2025-12-01 | EDIT | Notice (144) | −7,000 | -$17.5K | EDGAR |
| 2025-09-04 | EDIT | Sell (S) | −5,592 | -$14.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.